Ohno Yasuo | National Institute of Health Sciences
スポンサーリンク
概要
関連著者
-
Ohno Yasuo
National Institute of Health Sciences
-
Ohno Yasuo
Division Of Pharmacol. Mutagen. Nihs
-
KOJIMA Hajime
National Institute of Health Sciences
-
Ohno Yasuo
Div. Of Pharmacology Biological Safty Research Center National Institute Of Hygienic Sciences
-
OHNO Yasuo
Div.Pharmacol., Natl.Inst.Hlth.Sci.
-
KOJIMA Hajime
Japanese Center for the Validation of Alternative Methods (JaCVAM), National Institute of Health Sci
-
Ohe Yuichiro
国立医薬品食品衛生研究所
-
Ohe Yuichiro
Department Of Medical Oncology National Cancer Center Hospital
-
Kato Toshihiro
Japan Cosmetic Industry Association
-
Ohno Yasuo
第一三共安全性研究所
-
Ohno Y
Division Of Pharmacology National Institute Of Health Sciences
-
Okamoto Yuuko
Japan Cosmetic Industry Assoc.:kose Corp.
-
OKAMOTO Yuko
KOSE Corporation
-
Sakaguchi Hitoshi
Safety Science Research Laboratories, Kao Corporation
-
Chiba Katsuyoshi
Japan Cosmetic Industry Association
-
Kitajima Satoshi
Department Of Environmental Health And Toxicology Tokyo Metropolitan Institute Of Public Health
-
SAKEMI Kazue
Division of Pharmacology, National Institute of Health Sciences
-
TSUDA Mitsuhiro
Division of Pharmacology, National Institute of Health Sciences
-
Ueda Makoto
Division Of Pathology National Institute Of Health Sciences
-
Sakemi Kazue
Division Of Pharmacology National Institute Of Health Sciences
-
Mizuno Makoto
Kose Corporation Fundamental Research Center
-
Okamoto Yuko
資生堂
-
TAKAHASHI Atsushi
National Institute of Hygienic Sciences
-
Itagaki Hiroshi
Japan Cosmetic Industry Association
-
Tsuda Mitsuhiro
National Institute of Health Sciences
-
Tsuda Mitsuhiro
Division Of Pharmacology National Institute Of Health Sciences
-
Sakemi K
Division Of Pharmacology National Institute Of Health Sciences
-
Sakemi Kazue
Division Of Pharmacology And Biological Safety Research Center National Institute Of Health Sciences
-
Sakemi Kazue
Division Of Pharmacology National Institute Of Hygienic Sciences
-
Ashikaga Takao
Shiseido Co. Ltd.
-
Ashikaga Takao
Shiseido Safety And Analytical Research Center
-
Kosaka Nanae
Kao Corporation, Safety Science Research Laboratories
-
Sakaguchi Hitoshi
Kao Corporation, Safety Science Research Laboratories
-
YOSHIDA Mayumi
POLA CHEMICAL INDUSTORIES, INC.
-
KODAMA Tatsuji
LION CORPORATION
-
OKAMOTO Kenji
Kanebo Cosmetic Inc.
-
SONO Sakiko
Shiseido Co., Ltd.
-
YAMADA Takaaki
Nippon Menard Cosmetic Co., Ltd.
-
HASEGAWA Seiji
Nippon Menard Cosmetic Co., Ltd.
-
KUWAHARA Hirofumi
Kanebo Cosmetic Inc.
-
SATO Jun
LION CORPORATION
-
Yoshida Mayumi
Pola Chemical Industries Inc.
-
Okamoto Kenji
Kanebo Cosmetics Inc.
-
Yoshida Takemi
Showa Univ.
-
Inoue Tohru
Division Of Toxicol. Mutagen. Nihs
-
Takahashi Atsushi
Division Of Pharmacology National Institute Of Hygienic Sciences
-
OTA Naoko
POLA CHEMICAL INDUSTORIES, INC.
-
Inoue Tohru
Jacvam Steering Committee National Institute Of Health Science (nihs)
-
Sagami Fumio
第一三共安全性研究所
-
Sagami Fumio
Drug Safety Research Laboratories Eisai Co. Ltd.
-
Sagami Fumio
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Sagami Fumio
Department Of Drug Safety Research Eisai Kawashima Research Laboratories Eisai Co. Ltd.
-
Onodera Hiroshi
Pharmaceuticals And Medical Devices Agency
-
Hisada Shigeru
Safety Research Department Developmental Research Center, ASKA Pharmaceutical Co., Ltd.
-
Kawanishi Toru
Div. Of Drugs National Inst. Of Health Sci. Jpn
-
Kawanishi T
大妻女子大学 食物学科
-
Kawanishi T
Division Of Drugs National Institute Of Health Science
-
Kawanishi Toru
National Institute Of Health Sciences
-
Hisada Shigeru
Safety Research Department Developmental Research Center Aska Pharmaceutical Co. Ltd.
-
Hisada Shigeru
Safety Research Department Aska Pharmaceutical Co. Ltd.
-
KOBAYASI TADASHI
Kobe Pharmaceutical University
-
OHNO Tadao
RIKEN Cell Bank, RIKEN, Institute of Physical and Chemical Research
-
Kai Shuichi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Kai Shuichi
東京都健康安全研究センター
-
Kai Shuichi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Sagami Fumio
Japan Pharmaceutical Manufacturers Association (jpma) Qt Prodact
-
Makino Ikuyo
Japan Cosmetic Industry Assoc.:yakuruto Ltd.
-
OHNO Yasuo
Division of Pharmacology, National Institute of Health Science
-
Onodera Hiroshi
東京都健康安全研究センター
-
小野寺 博志
Division Of Pathology National Institute Of Health Sciences
-
Ohe Yuichiro
Thoracic Oncology Division National Cancer Center Hospital National Cancer Center
-
Ohno Yasuo
Division Of Pharmacology National Institute Of Health Sciences
-
Miyajima Atsuko
Div.pharmacol.natl.inst.hlth.sci.
-
Yoshida Midori
National Institute of Health Sciences
-
Ohno Y
Natl. Inst. Health Sci.
-
Yoshida Midori
Biological Safety Research Center National Institute Of Health Sciences
-
Yoshida M
National Agricultural Research Center For Hokkaido Region
-
Yoshida Midori
Division Of Pathology National Institute Of Health Sciences
-
Hisada Shigeru
Safety & Pharmacokinetics Research Department Teikoku Hormone Mfg. Co. Ltd.
-
Nakazawa Takahiro
Japan Pharmaceutical Manufacturers Association, Drug Evaluation Committee, Non-clinical Evaluation S
-
Kurokawa Misao
Japan Pharmaceutical Manufacturers Association, Drug Evaluation Committee, Non-clinical Evaluation S
-
Shinoda Kazutoshi
Pharmaceuticals and Medical Devices Agency
-
Kawamura Nobuyuki
European Federation of Pharmaceutical Industries and Associations
-
Yamazaki Tsuneyoshi
Kyoritsu University of Pharmacy, Kyoritsu University of Pharmacy
-
Fueki Osamu
Pharmaceuticals and Medical Devices Agency
-
OMORI Yoshihito
National Institute of Hygienic Sciences
-
Kawai Mutsufumi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Yoshida M
Genomic Sciences Center Riken
-
KASUYA YUTAKA
Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, University of Tokyo
-
Kotani Mayumi
Japan Cosmetic Industry Assoc.:sunstar Inc.
-
Yoshida Midori
Dept.pathol. Sasaki Inst.
-
Kasuya Y
Hoshi Univ. Tokyo Jpn
-
Umemura T
Division Of Pathology National Institute Of Health Sciences
-
Nishikawa Akiyoshi
Division of Pathology, National Institute of Health Sciences
-
高橋 通正
(独)産業技術総合研究所 環境管理技術研究部門
-
Komatsu Shinichi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
KANEKO Toyozo
Division of Cellular and Molecular Toxicology, Kangwon National University
-
Watanabe Rie
Japan Vilene Company, Ltd.
-
Hirose Akihiko
National Institute Of Health Sciences
-
Hirose Akihiko
National Inst. Of Health Sciences
-
Yasuhara K
Division Of Pathology National Institute Of Health Sciences
-
Yasuhara Kazuo
Division Of Pathology National Institute Of Health Sciences
-
Yasuhara Kazuo
National Institute of Health Sciences
-
Mitsumori Kunitoshi
National Institute of Health Sciences
-
Shimo T
National Inst. Health Sci. Tokyo
-
Ohe Yuichiro
Department Of Internal Medicine National Cancer Center Hospital
-
Takahashi M
National Inst. Health Sci. Tokyo
-
KAWASAKI Yasushi
Div of Cellular and Molecular Toxicology
-
Sawada Jun-ichi
National Institute Of Health Sciences
-
Hayashi Makoto
Division of Genetics and Mutagenesis
-
INOUE Tohru
Division of Toxicology
-
SUNOUCHI Momoko
Division of Pharmacology, National Institute of Health Sciences
-
SAKAI Toshiharu
Yamanouchi Pharm
-
INOUE Tadashi
Japan Pharmaceutical Manufactures Association
-
Sawada Jun-ichi
Division Of Functional Biochemistry And Genomics National Institute Of Health Sciences
-
Kodama Yukio
Division Of Pathology National Institute Of Health Sciences
-
荒戸 照世
杏林大学医学部生化学
-
荒戸 照世
杏林大・医・眼科
-
荒戸 照世
杏林大・医・第二生化
-
荒戸 照世
国立医薬品食品衛生研究所医薬品医療機器審査センター
-
Takahashi Atsushi
Division of Electrical, Electronic and Information Engineering, Osaka University
-
Ohsawa Hiroyuki
Japan Cosmetic Industry Assoc.:procter & Gamble Far East Inc.
-
Kitamura Y
Division Of Pathology National Institute Of Health Sciences
-
YOSHIDA Midori
Division of Pathology, National Institute of Health Sciences
-
Inoue Tohru
Biological Safety Research Center, National Institute of Health Sciences
-
TANAKA Noriho
Hatano Res. Inst. FDSC
-
SANBUISSHO Atsushi
Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd.
-
Kimura Kazuya
Japan Pharmaceutical Manufacturers Assoc. Drug Evaluation Committee Non-clinical Evaluation Subcommi
-
Ikeda Norikazu
Japan Cosmetic Industry Association
-
Kumazawa Toshihiko
Safety Assessment Laboratory Sanwa Kagaku Kenkyusho Co. Ltd.
-
Kumazawa Toshihiko
Pharmaceutical Research Laboratories Sanwa Kagaku Kenkyusho Co. Ltd.
-
Kudo Satoshi
Research Center, Kyorin Pharmaceutical Co., Ltd.
-
Ube Masayuki
Safety Research Laboratory (Kazusa), Mitsubishi Tanabe Pharma Corporation
-
Komatsu Shinichi
Pre-Clinical Development Department, Development & Medical Affairs Division, GlaxoSmithKline K.K.
-
HISADA SHIGERU
Japan Pharmaceutical Manufacturers Association
-
WAKATA AKIHIRO
Japan Pharmaceutical Manufacturers Association
-
Kurokawa Y
Division Of Toxicology National Institute Of Health Sciences
-
Ishida Seiichi
Division of Pharmacology, National Institute of Health Sciences
-
Itagaki Hiroshi
Shiseido Research Center
-
Sasa Hitoshi
Shiseido Research Center
-
Mitsumori Kunitoshi
National Institute Of Health Science
-
Nagao Taku
Food Safety Commission Of Japan
-
Nagao Taku
Laboratory Of Pharmacology & Toxicology Graduate School Of Pharmaceutical Sciences The Universit
-
Nagao Taku
Laboratory Of Pharmacology And Toxicology Graduate School Of Pharmaceutical Sciences The University
-
Ono Atsushi
Toxicogenomics Project National Institute Of Biomedical Innovation:national Institute Of Health Scie
-
Ono Atsushi
Biological Safety Research Center National Institute Of Health Science
-
Kudo Satoshi
Research Center Kyorin Pharmaceutical Co. Ltd.
-
Ube Masayuki
Safety Research Laboratory (kazusa) Mitsubishi Tanabe Pharma Corporation
-
Saito Minoru
Division Of Cellular & Molecular Toxicology National Institute Of Health Sciences
-
Saito Masako
Department Of Applied Physics University Of Tokyo:(present Address)institute For Solid State Physics
-
Shudo Koichi
National Institute Of Health Sciences
-
Ohe Yuichiro
Division Of Internal Medicine And Thoracic Oncology National Cancer Center Hospital
-
Kiyosawa Naoki
Toxicogenomics Project National Inst. Of Biomedical Innovation
-
Kiyosawa Naoki
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Hirota Kouichi
Division Of Pharmacology National Institute Of Hygienic Sciences
-
Hirota Kouichi
National Institute Of Hygienic Sciences Biological Safety Research Center Division Of Pharmabology
-
Heidel Shawn
Eli Lilly, Eli Lilly and Company
-
Kawakami Koji
Kyoto University
-
Kumagai Yuji
Showa University, School of Pharmaceutical Sciences
-
Inoue Tohru
National Institute of Health Sciences
-
NAITO Shinsaku
Japan Pharmaceutical Manufacturers Association, Drug Evaluation Committee, Non-clinical Evaluation S
-
FURUTA Shigeru
Japan Pharmaceutical Manufacturers Association, Drug Evaluation Committee, Non-clinical Evaluation S
-
KITADA Mitsukazu
Chiba University Hospital
-
UNNO Takashi
Pharmaceutical Research and Manufactures of America
-
KUREBAYASHI Hideo
Division of Medical Chemistry, National Institute of Hygienic Sciences
-
Ozawa Shogo
National Institute Of Health Sciences
-
戸田 敬
熊本大学理学部環境理学科
-
MATSUDA Rieko
National Institute of Health Sciences
-
Kitaura K
Univ. Tokushima School Of Medicine Tokushima
-
TAKAHASHI Michihito
School of pharmaceutical Sciences, Showa University
-
KAWASHIMA Kunio
National Institute of Health Sciences
-
MAYAHARA Hiroshi
Takeda Chemical Industries, Ltd.
-
SHODA Toshiyuki
National Institute of Health Sciences
-
Nishikawa Akiyoshi
Division Of Pathology Biology Safety Research Center National Institute Of Health Sciences
-
Sanbuissyo Atsushi
Medical Safety Research Laboratories, R & D Division, Daiichi-Sankyo Co., Ltd.
-
Takahashi Michihito
Pathology Peer Review Center
-
Isama Kazuo
National Institute of Health Sciences
-
Sakai Toki
Toxicology Laboratory Pharmaceutical Development Department Meiji Seika Kaisha Ltd.
-
Hayashi Yuzuru
National Institute of Health Sciences
-
MOMMA Junko
Division of Toxicology, Biological Safety Research Center, National Institute of Health Sciences
-
Shibata Michio
Japan Cosmetic Industry Assoc.:shiseido Co. Ltd.
-
Kawasaki Yasushi
National Institute of Vegetable and Tea Science
-
Ishida Seiichi
Division Of Pharmacology National Institute Of Health Sciences
-
Ishida Seiichi
National Institute Of Health Sciences
-
Iijima Masafumi
Showa University
-
OKAMOTO Yuko
Japan BCG Laboratory
-
Takaoka Masaya
Medicinal Safety Research Laboratories Daiichi-sankyo Co. Ltd.
-
SAIJO Kaoru
RIKEN Cell Bank, The Institute of Physical and Chemical Research (RIKEN)
-
Nishiyama Naohiro
Kao Corporation, Safety Science Research Laboratories
-
MAYAHARA Hiroshi
Drug Safety Research Laboratories, Takeda Chemical Industries, Ltd.
-
Yoshida Midori
National Agricultural Research Center For Hokkaido Region
-
Kawakami Koji
Dep. Of Pharmacoepidemiology Graduate School Of Medicine And Public Health Kyoto Univ.
-
SATO Michio
Div. of Medical Devices National Institute of Hygienic Sciences
-
TERAO Tadao
National Institute of Hygienic Sciences
-
IKEBUCHI Hideharu
National Institute of Hygienic Sciences
-
OHTA Naoko
POLA CHEMICAL INDUSTORIES, INC.
-
KOJIMA Hajime
JaCVAM Steering Committee, National Institute of Health Science (NIHS)
-
MASUDA Mitsuteru
JaCVAM Steering Committee, National Institute of Health Science (NIHS)
-
AKITA Masaharu
Kamakura Women's University
-
OHNO Yasuo
JaCVAM Steering Committee, National Institute of Health Science (NIHS)
著作論文
- Assessment of the human Cell Line Activation Test (h-CLAT) for Skin Sensitization ; Results of the First Japanese Inter-laboratory Study
- Collaborative work on evaluation of ovarian toxicity by repeated-dose and fertility studies in female rats
- Morphological characterization of the ovary under normal cycling in rats and its viewpoints of ovarian toxicity detection
- Safety assessment of biopharmaceuticals : Japanese perspective on ICH S6 guideline maintenance
- CURRENT OPINION : SAFETY EVALUATION OF DRUG METABOLITES IN DEVELOPMENT OF PHARMACEUTICALS
- Results of a Japanese ring study of a Human Cell Line Activation Test (h-CLAT) for predicting skin sensitization potential (1st report)
- P-103 Collaborative Work to Evaluate Toxicity on Male Reproductive Organs by A 2-Week Repeated-Dose Toxicity Study in Rats : 29)Summary.(Proceedings of the 27th Annual Meeting)
- Effects of pre-culture conditions on the human Cell Line Activation Test (h-CLAT) results : Results of the 4^ Japanese inter-laboratory study
- A study on serum difference on test results in the human Cell Line Activation Test (h-CLAT) : Results of 3^ Japanese inter-laboratory study
- A Study of the Criteria for Selection of THP-1 Cells in the Human Cell Line Activation Test (h-CLAT) : Results of 2^ Japanese Inter-laboratory Study
- JaCVAM statement on new alternatives to animal testing
- Review of an alternative to animal testing for safety evaluation of Quasi-drug
- "C-5 Validation of alternatives to eye irritation tests for cosmetic ingredients (Results of the first, second, and third validation).
- The Second Phase Validation Study of Alternative Methods to The Eye Irritation Test 11)Evaluation of EYTEX.
- THE SECOND PHASE VALIDATION STUDY OF ALTERNATIVE METHODS TO THE EYE IRRITATION TEST FOR COSMETIC INGREDIENTS 10)EVALUATION OF CYTOTOXICITY TEST ON CHL CELLS
- THE SECOND PHASE VALIDATION STUDY OF ALTERNATIVE METHOD TO THE EYE IRRITATION TEST 8.Evaluation of Cytotoxicity Test in SIRC Cells
- The second phase validation study of alternative methods to the eye irritation test (4) Evaluation of hemoglobin denaturation tests.
- The second phase validation study of alternative methods to the eye irritation test : Evaluation of Skin-squared ZK1100 and ZK1200 Models
- The second-phase validation of alternative methods to the eye irritation test. 9) Evaluation of cytotoxicity test on HeLa cells.
- THE SECOND PHASE OF VALIDATION STUDY OF ALTERNATIVE METHODS TO THE EYE IRRITATION TEST FOR COSMETIC INGREDIENTS 7) EVALUATION OF CYTOTOXICITY TESTS WITH Cornepack
- The second phase validation study of alternative methods to the eye irritation test (6)Evaluation of MATREX ^
- The second phase validation study of alternative methods to the eye irritation test for cosmetic ingredients 3) Evaluation of Hemolysis test.
- The second phase validation study of alternative methods to the eye irritation test (2) Evaluation of chorioallantoic membrane (CAM) tests.
- Results from Draize eye-irritation test and implications of their variations.
- Validation of alternative methods to eye irritaion test for safety evaluation of cosmetic ingredients, project and progress.
- Improvement in Reliability of Probabilistic Test of Significant Differences in GeneChip Experiments
- STUDIES ON NITROSAMINE FORMATION BY THE INTERACTION BETWEEN DRUGS AND NITRITE. I. : Measurement of the amount of nitrosamine formed in rat and guinea pig stomachs.
- "B-3 Toxicokinetic Study of 2-Mercaptobenzimidazole (MBI) and its Methylated Derivative (MMBI) in Rats after Single Oral-Dose Administration.
- Pharmacokinetic Study of Tris (2-chloroethyl) phosphate (TCEP) After Inhalation Exposure (Proceedings of the 22nd Symposium on Toxicology and Environmental Health)
- "B-2 Metabolic Study of Tris(2-Chloroethyl) Phosphate (TCEP) in vivo and in vitro.
- "B-1 Pharmacokinetic Study Of Tris(2-chloroethyl)phosphate (TCEP) in Rats After inhalation.
- LOSS OF VIABILITY AFTER DISULFIRAM TREATMENT WITHOUT PRECEDING DEPLETION OF INTRACELLULAR GSH
- MORPHINE METABOLISM IN ISOLATED HEPATOCYTES AND ITS IMPLICATIONS FOR HEPATOTOXICITY
- STUDIES ON NITROSAMINE FORMATION BY THE INTERACTION BETWEEN DRUGS AND NITRITE. II. : Hepatotoxicity by the simultaneous administration of several drugs and nitrite.
- Comparison of Thyroid Toxicity and Toxicokinetics of 2-Mercapto-4-methylbenzimidazole (4MeMBI) and its 5-Methyl Isomer (5MeMBI), Rubber antioxidant, in Rats by Single and Repeated Oral-Dose Administrations
- Endogenous Nitric Oxide Formation Stimulated by LPS in Hypothyroid Rats Induced by 2-Mercaptobenzimidazole (MBI)
- 2C-13 Toxicokinetic Study of 2-Mercapto-benzimidazole(MBI) and its Methylated Derivative (MMBI) in Rats Treated by Repeated Oral Administration - Metabolism and urinary Excretion
- 2C-12 Toxicokinetic Study of 2-Mercapto-benzimidazole(MBI) and its Methylated Derivative (MMBI) in Rats Treated by Repeated Oral Administration.
- Gene expression profiling in rat liver treated with various hepatotoxic-compounds inducing coagulopathy
- Application of in vitro cytotoxicity test for alternative method to systemic toxicity in vivo : metabolic activation system and treatment period
- Contribution of ICH on 3Rs in alternatives to animal experiments
- Toxicological bases for micro-dose study(Toxicological Bases for Micro-dose Study, Proceedings of the 32nd Annual Meeting)
- Intrductory Remarks : REPEATED DOSE TISSUE DISTRIBUTION STUDIES (Repeated dose tissue distribution studies
- Evaluation of DNA microarray results in the Toxicogenomics Project (TGP) consortium in Japan